New Phase Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 25

Employees

  • Latest Deal Type
  • Series A
  • (In Progress)

  • Latest Deal Amount
  • $25M

  • Investors
  • 4

New Phase General Information

Description

Developer of a medical technology platform designed to provide minimally invasive cancer treatment. The company offers nanoparticle-based therapy integrated with an electromagnetic induction system for targeted treatment, enabling healthcare providers treating cancer patients, to destroy cancerous cells while preserving healthy tissue and improving patient outcomes.

Contact Information

Website
newphase.co.il
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5 Odem Street
  • P.O Box 6761
  • Petah Tikva 4934829
  • Israel
Primary Industry
Therapeutic Devices
Corporate Office
  • 5 Odem Street
  • P.O Box 6761
  • Petah Tikva 4934829
  • Israel

New Phase Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

New Phase Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC (Series A) $25M In Progress Generating Revenue
10. Later Stage VC 30-Jun-2025 Completed Clinical Trials - Phase 1
9. Later Stage VC (Series 3) 02-Jun-2024 Completed Clinical Trials - Phase 1
8. Later Stage VC (Series 1) 01-Jan-2024 Completed Clinical Trials - Phase 1
7. Later Stage VC 02-Jan-2022 Completed Clinical Trials - Phase 1
6. Later Stage VC 01-Mar-2018 Completed Pre-Clinical Trials
5. Angel (individual) 01-Jan-2017 Completed Pre-Clinical Trials
4. Angel (individual) 01-Jan-2016 Completed Pre-Clinical Trials
3. Seed Round 01-Jan-2014 $2M $2.8M Completed Product In Beta Test
2. Angel (individual) 01-Aug-2013 $400K $800K Completed Product In Beta Test
To view New Phase’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

New Phase Patents

New Phase Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12667732-B2 Pulsed electromagnetic field transmission for nanoparticles Active 09-Oct-2024
US-20260097223-A1 Pulsed electromagnetic field transmission for nanoparticles Active 09-Oct-2024
US-20260306865-A1 Pulsed electromagnetic field transmission for nanoparticles Pending 09-Oct-2024
WO-2025088597-A1 Nanoparticle combination therapy for tumors Inactive 26-Oct-2023
CA-3054033-A1 Phase-change nanoparticle Active 22-Feb-2017 A61N1/406
To view New Phase’s complete patent history, request access »

New Phase Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

New Phase Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Katao Venture Partners Venture Capital Minority
Angel (individual) Minority
Real Life Innovations Venture Capital Minority
Innovation Authority Government Minority
To view New Phase’s complete investors history, request access »

New Phase FAQs

  • When was New Phase founded?

    New Phase was founded in 2013.

  • Where is New Phase headquartered?

    New Phase is headquartered in Petah Tikva, Israel.

  • What is the size of New Phase?

    New Phase has 25 total employees.

  • What industry is New Phase in?

    New Phase’s primary industry is Therapeutic Devices.

  • Is New Phase a private or public company?

    New Phase is a Private company.

  • What is New Phase’s current revenue?

    The current revenue for New Phase is .

  • How much funding has New Phase raised over time?

    New Phase has raised $68.6M.

  • Who are New Phase’s investors?

    Katao Venture Partners, , Real Life Innovations, and Innovation Authority have invested in New Phase.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process